CO:NYE-Global Cord Blood Corporation (USD)

COMMON STOCK | Diagnostics & Research | NYE

Last Closing Price

USD 4.16

Change

-0.30 (-6.73)%

Market Cap

USD 0.54B

Volume

0.26M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2020, it had three operating cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-02-26 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
TMO Thermo Fisher Scientific Inc

-1.39 (-0.31%)

USD178.93B 28.29 21.05
DHR Danaher Corporation

+0.41 (+0.19%)

USD155.89B 44.84 27.94
DHR-PA Danaher Corporation

+21.31 (+1.42%)

USD142.04B 315.80 N/A
PHG Koninklijke Philips N.V

-0.80 (-1.45%)

USD49.67B 34.94 17.28
A Agilent Technologies, Inc

-0.03 (-0.02%)

USD37.29B 47.02 29.88
IQV IQVIA Holdings Inc

+0.24 (+0.12%)

USD36.83B 134.65 23.23
MTD Mettler-Toledo International I..

+6.14 (+0.55%)

USD25.98B 44.56 32.19
LH Laboratory Corporation of Amer..

+3.38 (+1.43%)

USD23.06B 14.89 9.54
WAT Waters Corporation

-4.35 (-1.56%)

USD17.26B 33.28 23.28
DGX Quest Diagnostics Incorporated

+0.96 (+0.84%)

USD15.30B 10.95 8.36

ETFs Containing CO

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Diagnostics & Research)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.13% 80% B- 76% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.13% 80% B- 75% C
Trailing 12 Months  
Capital Gain 5.58% 6% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.58% 6% F 35% F
Trailing 5 Years  
Capital Gain -29.13% 20% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.13% 20% F 9% F
Average Annual (5 Year Horizon)  
Capital Gain 1.06% 25% F 52% F
Dividend Return 0.19% 10% F 4% F
Total Return 1.26% 25% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 56.05% 15% F 6% F
Risk Adjusted Return 2.24% 25% F 31% F
Market Capitalization 0.54B 16% F 42% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Diagnostics & Research)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.22 88% B+ 60% D-
Price/Book Ratio 0.83 100% A+ 84% B
Price / Cash Flow Ratio 0.87 74% C 79% C+
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 12.05% 53% F 73% C
Return on Invested Capital 12.55% 70% C- 83% B
Return on Assets 4.60% 55% F 78% C+
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 0.88 94% A 69% D+
Short Percent 0.53% 100% A+ 89% B+
Beta 0.36 95% A 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.